Back to Drug Index
EGYPTIAN PHARMACEUTICAL DIRECTORY

CONCENTRATED HAEMODIALYSIS SOLUTION-ACIDIC( B1 ) B.P. 2008

OFFICIAL RETAIL PRICE EGP 45.00
Active Molecule
HAEMODIALYSIS SOLUTION
Form & Route
General Form
Manufacturer
EL-FATH (FIPCO)
Therapeutic Class
STERILE SOLUTION
Cost-Saving Equivalent Available: You can save up to EGP 34.00 by switching to HAEMODIALYSIS CONCENTRATED SOLUTION (BICARBONATE FORMULA) (COMPONENT B) (EGP 11.00).
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
General Form • ALLMED MIDDLE EAST
EGP 45.00 Same Price
EGP 40.00 Saves EGP 5.00
EGP 40.00 Saves EGP 5.00
EGP 40.00 Saves EGP 5.00
EGP 45.00 Same Price
EGP 45.00 Same Price
EGP 79.00 +EGP 34.00
EGP 18.00 Saves EGP 27.00
EGP 79.00 +EGP 34.00
EGP 79.00 +EGP 34.00
EGP 40.00 Saves EGP 5.00
General Form • NEW LIFE CO.
EGP 40.00 Saves EGP 5.00
General Form • NEW LIFE CO.
EGP 40.00 Saves EGP 5.00
General Form • NEW LIFE CO.
EGP 40.00 Saves EGP 5.00
EGP 79.00 +EGP 34.00
EGP 79.00 +EGP 34.00
EGP 18.00 Saves EGP 27.00
EGP 18.00 Saves EGP 27.00
EGP 79.00 +EGP 34.00
EGP 79.00 +EGP 34.00
General Form • PHARMACEUTICAL SOLUTION INDUSTRIES > AL KAMAL IMPORTING & MARKETING CO
EGP 32.00 Saves EGP 13.00
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 40.50 Saves EGP 4.50
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 54.00 +EGP 9.00
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 54.00 +EGP 9.00
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 18.00 Saves EGP 27.00
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 18.00 Saves EGP 27.00
General Form • HAIDYLENA FOR ADVANCED MEDICAL INDUSTRIES
EGP 18.00 Saves EGP 27.00
General Form • EL MANSOURA FOR MEDICAL AND CHEMICAL INDUSTRIES
EGP 40.00 Saves EGP 5.00
General Form • EL MANSOURA FOR MEDICAL AND CHEMICAL INDUSTRIES
EGP 11.00 Saves EGP 34.00
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.

System Notice

Confirm Action